Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cell secretome for diabetic foot ulcer
IRCT20131009014957N16Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2023
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of human umbilical cord mesenchymal stem cell secretome in diabetic foot ulcer (DFU) (4 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Participant entry and retention rate, Change in diabetic foot ulcer size at 8 weeks and 1 more. Started Oct 2023; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cell secretome
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on IRCT20131009014957N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131009014957N16.